Treatment Interruption and Regimen Change in Firstgeneration versus Second-generation Tyrosine Kinase Inhibitors used as First-line Therapy for Chronic Myeloid Leukemia

Treatment Interruption and Regimen Change in Firstgeneration versus Second-generation Tyrosine Kinase Inhibitors used as First-line Therapy for Chronic Myeloid Leukemia

# Background Research has shown that treatment interruptions are associated with worse failure-free survival in chronic myeloid leukemia (CML); however they are commonly used in clinical trials to manage adverse events. # Objectives This study assessed the comparative rates of treatment interruptio...

Full description

Saved in:
Bibliographic Details
Main Authors: Melea A. Ward, Gang Fang, Kristy L. Richards, Christine M. Walko, Stephanie R. Earnshaw, Laura E. Happe, Susan J. Blalock
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2015-04-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/9899
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items